SNPs associated with colorectal cancer at 15q13.3 affect risk enhancers that modulate GREM1 gene expression.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
03 2021
Historique:
received: 05 02 2020
revised: 12 08 2020
accepted: 03 11 2020
pubmed: 22 1 2021
medline: 1 4 2022
entrez: 21 1 2021
Statut: ppublish

Résumé

Several genome wide association studies of colorectal cancer (CRC) have identified single nucleotide polymorphisms (SNPs) on chromosome 15q13.3 associated with CRC risk. To identify functional variant(s) underlying this association, we investigated SNPs in linkage disequilibrium with the risk-associated SNP rs4779584 that overlapped regulatory regions/enhancer elements characterized in colon-related tissues and cells. We identified several SNP-containing regulatory regions that exhibited enhancer activity in vitro, including one SNP (rs1406389) that correlated with allele-specific effects on enhancer activity. Deletion of either this enhancer or another enhancer that had previously been reported in this region correlated with decreased expression of GREM1 following CRISPR/Cas9 genome editing. That GREM1 is one target of these enhancers was further supported by an expression quantitative trait loci correlation between rs1406389 and GREM1 expression in the transverse but not sigmoid colon in the Genotype-Tissue Expression dataset. Taken together, we conclude that the 15q13.3 region contains at least two functional variants that map to distinct enhancers and impact CRC risk through modulation of GREM1 expression.

Identifiants

pubmed: 33476087
doi: 10.1002/humu.24166
pmc: PMC7898835
mid: NIHMS1665798
doi:

Substances chimiques

GREM1 protein, human 0
Intercellular Signaling Peptides and Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-245

Subventions

Organisme : NCI NIH HHS
ID : R01 CA204279
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA143237
Pays : United States
Organisme : NHGRI NIH HHS
ID : U41 HG007823
Pays : United States

Informations de copyright

© 2021 The Authors. Human Mutation Published by Wiley Periodicals LLC.

Références

Hum Genet. 2019 Oct;138(10):1091-1104
pubmed: 31230194
Nat Genet. 2013 Feb;45(2):191-6
pubmed: 23263487
Am J Hum Genet. 2011 May 13;88(5):586-98
pubmed: 21565292
Int J Cancer. 2014 Aug 15;135(4):948-55
pubmed: 24448986
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
Eur J Cancer. 2011 Jul;47(11):1699-707
pubmed: 21402474
Cell Rep. 2014 Aug 21;8(4):983-90
pubmed: 25131200
Nat Genet. 2008 May;40(5):631-7
pubmed: 18372901
J Natl Cancer Inst. 2019 Feb 1;111(2):146-157
pubmed: 29917119
PLoS Genet. 2011 Jun;7(6):e1002105
pubmed: 21655089
Hum Mutat. 2021 Mar;42(3):237-245
pubmed: 33476087
Int J Cancer. 2011 Oct 1;129(7):1635-42
pubmed: 21128281
Nat Genet. 2008 Dec;40(12):1426-35
pubmed: 19011631
Gastroenterology. 2013 Apr;144(4):799-807.e24
pubmed: 23266556
Carcinogenesis. 2012 Mar;33(3):613-9
pubmed: 22235025
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3062-7
pubmed: 19843678
PLoS One. 2014 Nov 06;9(11):e111914
pubmed: 25375357
Cells. 2019 Oct 19;8(10):
pubmed: 31635067
Nat Genet. 2012 May 06;44(6):699-703
pubmed: 22561515
Carcinogenesis. 2014 Sep;35(9):2025-30
pubmed: 24753543
Nat Med. 2015 Jan;21(1):62-70
pubmed: 25419707
Nucleic Acids Res. 2003 Jul 1;31(13):3651-3
pubmed: 12824386
Nat Commun. 2019 May 14;10(1):2154
pubmed: 31089142
Bioinformatics. 2002 Feb;18(2):333-4
pubmed: 11847087
Int J Epidemiol. 2020 Feb 1;49(1):259-269
pubmed: 31038671
Int J Cancer. 2018 Feb 1;142(3):540-546
pubmed: 28960316
Fam Cancer. 2019 Jan;18(1):63-66
pubmed: 29804199
Hum Mol Genet. 2013 Dec 15;22(24):5075-82
pubmed: 23904454
Genome Res. 2014 Jan;24(1):1-13
pubmed: 24196873
Int J Cancer. 2014 May 15;134(10):2330-41
pubmed: 24154973
Hum Mol Genet. 2014 Sep 1;23(17):4729-37
pubmed: 24737748
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Hum Mol Genet. 2014 Apr 15;23(8):2198-209
pubmed: 24256810
Biol Chem. 2015 Feb;396(2):163-83
pubmed: 25153376
Nat Genet. 2007 Nov;39(11):1315-7
pubmed: 17934461
Carcinogenesis. 2012 Jan;33(1):108-12
pubmed: 22045029
Nat Genet. 2014 Jun;46(6):533-42
pubmed: 24836286
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nat Genet. 2019 Jan;51(1):76-87
pubmed: 30510241
Genes Chromosomes Cancer. 2016 Jan;55(1):95-106
pubmed: 26493165
Nat Genet. 2008 May;40(5):623-30
pubmed: 18372905
Hum Genet. 2012 Feb;131(2):217-34
pubmed: 21761138
Nat Commun. 2017 Feb 07;8:14400
pubmed: 28169291
Nat Genet. 2008 Jan;40(1):26-8
pubmed: 18084292
Science. 2012 May 11;336(6082):736-9
pubmed: 22499810
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15418-23
pubmed: 17881565

Auteurs

Barbara K Fortini (BK)

Keck Graduate Institute, Claremont, California, USA.

Stephanie Tring (S)

Molecular Genomics Core, University of Southern California, Los Angeles, California, USA.

Matthew A Devall (MA)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.

Mourad Wagdy Ali (MW)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.

Sarah J Plummer (SJ)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.

Graham Casey (G)

Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH